Nossin (Levocetirizine Dihydrochloride)

Levocetirizine works by selectively blocking peripheral H1 histamine receptors. By preventing histamine from binding to these receptors, it stops the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation, thereby reducing the classic signs of an allergic reaction such as itching, swelling, and nasal discharge.

The appropriate dose of Nossin is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and clinical response. Dosage recommendations are individualized, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for levocetirizine in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against possible risks before prescribing Nossin to pregnant or nursing mothers. If used, the patient should be monitored closely for any adverse effects on the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Nossin. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nossin (levocetirizine) is the active enantiomer of cetirizine, offering a more selective H1‑receptor blockade and often a lower incidence of sedation compared with first‑generation antihistamines. Compared with other second‑generation agents, its efficacy in allergic rhinitis and urticaria is comparable, while its safety profile remains favorable for most patients.

Nossin should be stored at room temperature, below 25 °C, in its original packaging. The container should be kept away from moisture, direct sunlight, and excessive heat to maintain product stability throughout its shelf life.

Nossin is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water and avoid crushing or chewing unless specifically instructed.

While generally well‑tolerated, Nossin can cause rare but serious adverse events such as angioedema, severe skin reactions (including Stevens‑Johnson syndrome), anaphylaxis, thrombocytopenia, and hepatic injury. Patients should seek immediate medical attention if they experience swelling of the face or throat, widespread rash, or signs of liver dysfunction.

Nossin is contraindicated in individuals with known hypersensitivity to levocetirizine, cetirizine, or any excipients in the formulation. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required, and for those taking interacting medications that could increase sedation or plasma levels.